Daisuke Nonaka

Summary

Affiliation: Istituto Nazionale Tumori
Country: Italy

Publications

  1. ncbi request reprint Thymic mucoepidermoid carcinomas: a clinicopathologic study of 10 cases and review of the literature
    Daisuke Nonaka
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Am J Surg Pathol 28:1526-31. 2004
  2. ncbi request reprint Cylindroma of the breast of skin adnexal type: a study of 4 cases
    Daisuke Nonaka
    Department of Pathology, National Cancer Institute, Via G Venezian 1, 20133 Milan, Italy
    Am J Surg Pathol 28:1070-5. 2004
  3. ncbi request reprint Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients
    Andrea Anichini
    Unit of Human Tumors Immunobiology and Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer Res 66:6405-11. 2006
  4. ncbi request reprint Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion
    Marcello Deraco
    Department of Surgery, National Cancer Institute, Via Venezian, 1, 20133, Milan, Italy
    Ann Surg Oncol 13:229-37. 2006
  5. pmc Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma
    Alla V Ivanova
    Department of Cardiothoracic Surgery, Langone School of Medicine, New York University, New York, New York, USA
    Clin Cancer Res 15:2602-11. 2009
  6. ncbi request reprint Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma
    Aliza L Leiser
    Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 101:86-91. 2006
  7. doi request reprint PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck
    Luc G Morris
    Head and Neck Surgery Service, New York University Cancer Institute, New York, New York
    Head Neck 30:771-5. 2008
  8. doi request reprint Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors
    Daisuke Nonaka
    Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
    J Cutan Pathol 35:1014-9. 2008
  9. pmc Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
    Sylvia Adams
    Department of Medicine, Division of Medical Oncology, New York University Cancer Institute, School of Medicine, New York, NY 10016, USA
    J Immunol 181:776-84. 2008
  10. doi request reprint Sox10: a pan-schwannian and melanocytic marker
    Daisuke Nonaka
    Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
    Am J Surg Pathol 32:1291-8. 2008

Collaborators

Detail Information

Publications24

  1. ncbi request reprint Thymic mucoepidermoid carcinomas: a clinicopathologic study of 10 cases and review of the literature
    Daisuke Nonaka
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Am J Surg Pathol 28:1526-31. 2004
    ..Among these variants, thymic mucoepidermoid carcinomas morphologically similar to the homonymous salivary gland counterparts are particularly unusual; only 9 cases for which clinicopathologic features were available have been reported...
  2. ncbi request reprint Cylindroma of the breast of skin adnexal type: a study of 4 cases
    Daisuke Nonaka
    Department of Pathology, National Cancer Institute, Via G Venezian 1, 20133 Milan, Italy
    Am J Surg Pathol 28:1070-5. 2004
    ..This is the second reported case of this hereditary syndrome with extracutaneous manifestations and the first case in which the breast is involved...
  3. ncbi request reprint Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients
    Andrea Anichini
    Unit of Human Tumors Immunobiology and Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy
    Cancer Res 66:6405-11. 2006
    ..These results suggest that quantitative variations in APM component and HLA expression in melanoma lesions from AJCC stage III and IV patients may have an effect on the clinical course of the disease...
  4. ncbi request reprint Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion
    Marcello Deraco
    Department of Surgery, National Cancer Institute, Via Venezian, 1, 20133, Milan, Italy
    Ann Surg Oncol 13:229-37. 2006
    ..We performed a prognostic analysis in a cohort of DMPM patients treated homogeneously by cytoreductive surgery and intraperitoneal hyperthermic perfusion (IPHP)...
  5. pmc Protumorigenic role of HAPLN1 and its IgV domain in malignant pleural mesothelioma
    Alla V Ivanova
    Department of Cardiothoracic Surgery, Langone School of Medicine, New York University, New York, New York, USA
    Clin Cancer Res 15:2602-11. 2009
    ..We find that one of the ECM proteins, HAPLN1, is overexpressed in the majority of mesotheliomas. This study was designed to characterize the protumorigenic role of HAPLN1 in mesothelioma...
  6. ncbi request reprint Apoptotic and cell cycle regulatory markers in uterine leiomyosarcoma
    Aliza L Leiser
    Developmental Chemotherapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Gynecol Oncol 101:86-91. 2006
    ..A secondary aim was to examine if the apoptotic and cell cycle regulatory protein expression profile of uterine leiomyosarcoma is potentially useful for clinical prognostic purposes...
  7. doi request reprint PNL2 melanocytic marker in immunohistochemical evaluation of primary mucosal melanoma of the head and neck
    Luc G Morris
    Head and Neck Surgery Service, New York University Cancer Institute, New York, New York
    Head Neck 30:771-5. 2008
    ..Histologic diagnosis of mucosal melanoma of the head and neck is difficult, requiring immunohistochemical stains which are less reliable than in cutaneous lesions. PNL-2 is a novel marker that has not been examined in mucosal melanoma...
  8. doi request reprint Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors
    Daisuke Nonaka
    Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
    J Cutan Pathol 35:1014-9. 2008
    ..S100 family of proteins consists of over 20 members. We report on S100 subtypes in malignant melanomas (MMs), and BPNSTs and MPNSTs to investigate differential expression...
  9. pmc Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
    Sylvia Adams
    Department of Medicine, Division of Medical Oncology, New York University Cancer Institute, School of Medicine, New York, NY 10016, USA
    J Immunol 181:776-84. 2008
    ..Imiquimod's adjuvant effects require further evaluation and likely need optimization of parameters such as formulation, dose, and timing relative to Ag exposure for maximal immunogenicity...
  10. doi request reprint Sox10: a pan-schwannian and melanocytic marker
    Daisuke Nonaka
    Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
    Am J Surg Pathol 32:1291-8. 2008
    ..Our results indicate that Sox10 will serve as a more sensitive and specific marker for the diagnosis of melanocytic and schwannian tumors than S100 protein...
  11. doi request reprint Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas
    Daisuke Nonaka
    Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
    Am J Surg Pathol 32:1566-71. 2008
    ....
  12. pmc Genomic events associated with progression of pleural malignant mesothelioma
    Sergey V Ivanov
    Department of Cardiothoracic Surgery, Thoracic Surgery Laboratory, NYU Langone Medical Center, New York, NY, USA
    Int J Cancer 124:589-99. 2009
    ..2), FUS1 and PL6 (3p21.3), DNAJA1 (9p21.1) and CDH2 (18q11.2-q12.3). Imbalances seen by ROMA were confirmed by Affymetrix genome analysis in a subset of samples...
  13. ncbi request reprint Extraneural hemangioblastoma: a report of 5 cases
    Daisuke Nonaka
    Department of Pathology, New York University Medical Center, 560 First Avenue, New York, NY 10016, USA
    Am J Surg Pathol 31:1545-51. 2007
    ....
  14. ncbi request reprint Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms
    Daisuke Nonaka
    Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
    Am J Surg Pathol 31:1038-44. 2007
    ..CD205 is a sensitive and specific marker for thymoma but its sensitivity to thymic carcinoma is lower than CD5 and CD117...
  15. ncbi request reprint Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma
    Mario M Leitao
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 101:1455-62. 2004
    ..The authors also sought to assess the prognostic value of ER, PR, and AR expression in LMS...
  16. doi request reprint A study of immunohistochemical differential expression in pulmonary and mammary carcinomas
    Michael Yang
    Department of Pathology, New York University School of Medicine, New York, NY 10016, USA
    Mod Pathol 23:654-61. 2010
    ..Caution should be taken in the interpretation of GCDFP-15 due to its occasional expression in pulmonary adenocarcinomas...
  17. ncbi request reprint Immunohistochemical evaluation of necrotic malignant melanomas
    Daisuke Nonaka
    Department of Pathology, New York University Medical Center, New York, NY 10016, USA
    Am J Clin Pathol 127:787-91. 2007
    ..Our study demonstrated that a combination of antibodies to HMB-45, tyrosinase, and PNL2 detected melanocytic differentiation in necrotic areas in 80% of cases...
  18. ncbi request reprint Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
    Dario Baratti
    Department of Surgery, National Cancer Institute, Milan, Italy
    Ann Surg Oncol 15:526-34. 2008
    ..We reviewed our 10-year monoinstitutional case series to identify selection factors predicting postoperative outcome...
  19. ncbi request reprint Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution
    Daisuke Nonaka
    Department of Pathology, National Cancer Institute, Milan, Italy
    Cancer 104:2181-8. 2005
    ..In the current study, the authors report the clinicopathologic features of patients with peritoneal diffuse malignant mesothelioma (DMM) who were treated in a uniform fashion at a single institution to assess prognostic factors...
  20. ncbi request reprint A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-alpha in metastatic melanoma patients
    Lorenzo Pilla
    Unit of Immunotherapy of Human Tumors, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Cancer Immunol Immunother 55:958-68. 2006
    ..Clinical activity was limited to SD. However, both immunological and clinical responses were not improved as compared with those recorded in a previous study investigating HSPPC-96 monotherapy...
  21. ncbi request reprint NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients
    Cristina Maccalli
    Unit of Immunotherapy of Human Tumors, Istituto Nazionale Tumori, Milan, Italy
    Clin Cancer Res 13:7459-68. 2007
    ..The role of NKG2D receptor in antitumor immunosurveillance has not been completely clarified. We addressed this issue by investigating the involvement of this receptor in tumor-specific immunologic response in melanoma patients...
  22. ncbi request reprint Combined high-grade basal cell carcinoma and malignant melanoma of the skin ("malignant basomelanocytic tumor"): report of two cases and review of the literature
    Jaime Rodriguez
    Department of Pathology, National Cancer Institute, Milan, Italy
    Am J Dermatopathol 27:314-8. 2005
    ..We favor the hypothesis of a tumor with bidirectional keratinocytic and melanocytic differentiation, an exceptionally rare event...
  23. ncbi request reprint Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesicles
    Roberta Mortarini
    Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy
    Cancer Res 65:3428-36. 2005
    ..These data suggest that LIGHT constitutively expressed in human melanoma cells and microvesicles may contribute to regulate T-cell responses to tumor cells...
  24. ncbi request reprint Undifferentiated large cell carcinoma of the thymus associated with Castleman disease-like reaction: a distinctive type of thymic neoplasm characterized by an indolent behavior
    Daisuke Nonaka
    Department of Pathology, National Cancer Institute, Milan, Italy
    Am J Surg Pathol 29:490-5. 2005
    ..The first hypothesis is favored, with the added suggestion that the CD-like reaction may bear a relationship to the peculiarly indolent behavior that these tumors exhibit...